NanoViricides
NNVC
#10351
Rank
A$51.5 M
Marketcap
A$2.24
Share price
2.29%
Change (1 day)
-15.51%
Change (1 year)

Earnings for NanoViricides (NNVC)

Earnings in 2026 (TTM): -A$12.08 Million

According to NanoViricides's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$11.92 Million, an increase over its 2024 earnings that were of -A$13.42 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for NanoViricides from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$12.08 Million1.37%
2025 -A$11.92 Million-11.17%
2024 -A$13.42 Million0.09%
2023 -A$13.4 Million35.83%
2022 -A$9.87 Million-20.96%
2021 -A$12.49 Million-40.3%
2020 -A$20.91 Million86.2%
2019 -A$11.23 Million0.09%
2018 -A$11.22 Million-25.39%
2017 -A$15.04 Million-6.68%
2016 -A$16.12 Million114.25%
2015 -A$7.52 Million-5.43%
2014 -A$7.96 Million-59.73%
2013 -A$19.75 Million106.16%
2012 -A$9.58 Million5.57%
2011 -A$9.08 Million6.42%
2010 -A$8.53 Million93.61%
2009 -A$4.41 Million-4.07%
2008 -A$4.6 Million19.12%
2007 -A$3.86 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
A$15.36 B-132,691.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$18.83 B-162,651.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.74 B-118,713.42%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$14.33 B-123,835.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-A$92.32 Million 696.69%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-A$0.66 Billion 5,513.34%๐Ÿ‡บ๐Ÿ‡ธ USA